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Eicosapentaenoic Acid Incorporation in Membrane Phospholipids Modulates Receptor-mediated Phospholipase C and
Membrane Fluidity in Rat Ventricular Myocytes in Culture. Journal of Molecular and Cellular Cardiology (1996) 28,
1097±1108. The in¯uence of increased incorporation of linoleic acid (18:2n-6) and eicosapentaenoic acid (20:5n-3)
in membrane phospholipids on receptor-mediated phospholipase Cb (PLC-b) activity in cultured rat ventricular myo-
cytes was investigated. For this purpose, cells were grown for 4 days in control, stearic acid (18:0)/oleic acid (18:1n-
9), 18:2n-6 and 20:5n-3 enriched media, and subsequently assayed for the basal- and phenylephrine- or endothelin-
1-induced total inositol phosphate formation. The various fatty acid treatments resulted in the expected alterations of
fatty acid composition of membrane phospholipids. In 18:2n-6-treated cells, the incorporation of this 18:2n-6 in the
phospholipids increased from 17.1 mol % in control cells to 38.9 mol %. In 20:5n-3-treated cells, incorporation of 20:
5n-3 and docosapentaenoic acid (22:5n-3) in the phospholipids increased from 0.5 and 2.7 mol % in control cells to
23.2 and 9.7 mol %, respectively. When 20:5n-3-treated cells were stimulated with phenylephrine or endothelin-1,
the inositolphosphate production decreased by 33.2% and increased by 43.4%, respectively, as compared to cells grown
in control medium. No effects were seen in 18:2n-6-treated cells. When 18:0/18:1n-9-treated cells were stimulated with
endothelin-1, inositolphosphate formation increased by 26.4%, whereas phenylephrine-stimulated inositolphosphate
formation was not affected. In saponin-permeabilized cells, that were pre-treated with 20:5n-3, the formation of total
inositolphosphates after stimulation with GTPcS, in the presence of Ca2+, was inhibited 19.3%. This suggests that the
20:5n-3 effect on intact cardiomyocytes could be exerted either on the level of agonist±receptor, receptor±GTP-binding-
protein coupling or GTP-binding-protein±PLC-b interaction. Investigation of the time course of saponin-induced per-
meabilization of the cardiomyocytes, measured by the release of lactate dehydrogenase, unmasked a slight decrease in
the rate of permeabilization by 20:5n-3 pretreatment, indicating a protective effect. This led the authors to measure
the cholesterol/phospholipid molar ratio, the double bond index of membrane phospholipids, and the membrane
¯uidity; the latter by using a diphenylhexatriene probe. In 20:5n-3-pretreated cells, a strong increase in the cholesterol/
phospholipid molar ratio (from 0.23 to 0.39), a marked increase in the double bond index (from 1.76 to 2.33), and a
slight decrease in ¯uidity (steady-state anisotropy rss of the diphenylhexatriene probe increased from 0.196 to 0.217)
were observed. Thus, treatment of cardiomyocytes for 4 days with 20:5n-3, but not with 18:2n-6, causes alterations
ofreceptor-mediatedphospholipaseCbactivity. Acausalrelationshipmayexistbetweenthe20:5n-3-inducedalterations
of the physicochemical properties in the bilayer and of the agonist-stimulated phosphatidylinositol cycle activity.
 1996 Academic Press Limited
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or n-3 PUFAs could prevent and terminate iso-Introduction
proterenol-induced arrhythmias.
Modi®cation of the fatty acyl composition of thePolyunsaturated fatty acids (PUFAs) have structural
membrane phospholipids can in¯uence many stepsroles in phospholipids of all cell membranes in the
of the PtdIns signalling cascade. It has been shown,body, in¯uencing membrane viscosity and per-
for example, that incorporation of n-3 and n-6meability and, associated herewith, the function of
PUFAs in the membrane phospholipids was as-membrane proteins. Moreover, different types of
sociated with a decreased af®nity of the a1-ad-eicosanoids are formed from the fatty acids
renoceptors for their antagonist ligand [3H]prazosinarachidonic acid (20:4n-6) and eicosapentaenoic
in heart muscle (SkuÂ ladoÂttir et al., 1993). In isolatedacid (20:5n-3). In general, eicosanoids derived from
atrial cells, Gk protein kinetics involved in the stimu-20:5n-3 are weak agonists compared to the
lation of inwardly rectifying K+ current by mus-corresponding compounds derived from 20:4n-6
carinic receptor agonist were demonstrated to be(Harris, 1989; Leaf, 1994; Sassen et al., 1994).
modulated by 20:4n-6-derived metabolites (SchererPolyunsaturated fatty acids also have important
and Breitwieser, 1990). Furthermore, the functionfunctions in modulating triglyceride and cholesterol
of protein kinase C (PKC) isozymes may be affectedmetabolism. Epidemiological studies have reported
by either free PUFAs or by alteration of the mo-favourable effects in prevention of cardiovascular
lecular species of 1,2-diacylglycerol [ (1,2)DAG] duedisease by the regular ingestion of ®sh, containing
to changed fatty acid composition of the phos-n-3 PUFAs, although the responsible mechanism
pholipid source (Bordoni et al., 1992; Graber et al.,remains obscure (Bang et al., 1976; Kagawa et al.,
1994).1982; Kromhout et al., 1985; Lamers et al., 1987;
Obviously, we need to learn more about theLeaf, 1994). Nevertheless, many experimental stud-
effects of incorporation of n-3 and n-6 PUFAs inies have provided evidence that n-3 PUFAs have
membrane phospholipids on structure and functiondiverse and often potent actions on e.g. platelet,
of the sarcolemma, in terms of the various steps ofendothelial cell, and vascular smooth muscle func-
the transmembrane signalling by the PtdIns cycle,tion, which may explain many of their salutary
and the physicochemical properties such as ¯uidityeffects on cardiovascular diseases (Goodnight,
of the bilayer, cholesterol content and resistance to1991).
permeabilizing agents. In the present study, primaryThe phosphatidylinositol (PtdIns) cycle is a sig-
cultures of spontaneously beating, neonatal ratnalling pathway involved in receptor-mediated bio-
ventricular myocytes were used to investigate thelogical responses such as platelet aggregation,
in¯uence of addition of n-6 and n-3 PUFAs to thesmooth muscle contraction, and formation of re-
culture medium on their spontaneous contractilelaxing and contracting factors by endothelial cells.
activity and on the receptor-mediated activationA common mechanism of n-3 and n-6 PUFAs in
of PLC-b. After permeabilization of the cells withthese biological responses may be by interference
saponin, the authors examined the effects of n-3with the functioning of the PtdIns cycle. Previously,
and n-6 PUFAs on PLC-b at the level of its GTPthe authors reported that cultured cardiomyocytes,
binding protein (G protein) and Ca2+ activation.which were pretreated with linoleic acid (18:2n-6)
As 20:5n-3 pretreatment of the cardiomyocytesor 20:5n-3, showed less phospholipase C-b activity
appeared to decrease the rate of cell per-in response to a1-adrenoceptor stimulation (Lamers
meabilization by saponin, the membrane cholesterolet al., 1992). Recently, this was con®rmed by Wood-
contents and membrane ¯uidity were also meas-cock et al. (1995), who showed that feeding rats
ured.with n-3 and n-6 PUFAs caused a depression of
total release of inositol phosphates (InsPn) in left
atrial tissue in the presence or absence of no- Materials and Methods
repinephrine. In accordance, Reibel et al. (1988)
demonstrated that dietary n-6 and n-3 PUFAs at- Materials
tenuated the a1-adrenergic-mediated positive in-
otropy in perfused rat hearts. Furthermore, it was Phenylephrine (PHE) was obtained from Sigma (St
Louis, MO, USA) and endothelin-1 (ET-1) was fromshown by Kang and Leaf (1995) that dietary n-6
Please address all correspondence to: J. M. J. Lamers, Department of Biochemistry, Cardiovascular Research Institute COEUR, Faculty
of Medicine and Health Sciences, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands.
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Peninsula Laboratories (Belmont, CA, USA). The each); (3) growth medium supplemented with 18:
2n-6 (214 l); and (4) growth medium sup-four-well Multidish and single culture dishes (dia-
meter 35 mm) were from Nunc (Roskilde, Den- plemented with 20:5n-3 (214 l), as described
previously (Lamers et al., 1992). After 2 days,mark), and the culture medium Ham F10 was from
Gibco (Paisley, UK). Fetal calf serum, horse serum the cultures were renewed with their concurring
enriched medium. Treatment with fatty acids didand penicillin/streptomycin were obtained from
Boehringer (Mannheim, Germany). Trypsin (type not result in cell density or hypertrophic changes
as was tested by assessment of the protein contentIII) was from Sigma. Myo[2-3H]Ins (17±19 Ci/
mmol) was obtained from Amersham International and protein over DNA ratio, respectively. For in-
stance, protein contents (mg) per mg DNA in the(Amersham, UK). TMA-DPH (1-(4-trimethylammo-
nium-phenyl)-6-phenyl-1,3,5-hexatriene, p-tolu- treated cells were 43.1±1.7 (Control), 45.5±0.7
(18:0/18:1n-9), 42.6±2.6 (18:2n-6) andenesulphonate) was obtained from Molecular
Probes (Eugene, OR, USA). A2C (2-(2-methoxy- 43.8±1.4 (20:5n-3). All experiments were per-
formed 4±5 days after plating the cells.ethoxy)ethyl 8-(cis-2-n-octylcyclopropyl)-octa-
noate) as well as the free fatty acids oleic acid
(cis-9-octadecenoic acid, 18:1n-9), stearic acid
(octadecanoic acid, 18:0), linoleic acid (cis-9,12-
Separation of the phospholipids and quanti®cation of the
octadecadienoic acid, 18:2n-6) and cis-5,8,11,14,
fatty acid methyl esters
17-eicosapentaenoic (20:5n-3) acid were from
Sigma. Dowex AG 1-X8 (100±200 mesh formate
To examine the incorporation of supplemented fatty
form) was from BioRad Laboratories (Richmond,
acids in the phospholipid fraction after 4±5 days,
CA, USA). Free cholesterol was determined using a
the cardiomyocytes were rinsed with cold buffer,
kit (Boehringer-Mannheim). All other chemicals
scraped and extracted with organic solvents as
were of analytical grade.
described previously (Lamers et al., 1992). Brie¯y,
the phospholipid fractions were separated from the
triglyceride, diacylglycerol, cholesterol and un-
Cell culture
esteri®ed fatty acid fractions by thin layer chromato-
graphy. To separate the fatty acid methyl esters, a
Primary cultures of neonatal ventricular myocytes
CP9000 capillary column chromatograph (Chrom-
were prepared from 2-day-old Wistar rats as de-
pack, Middelburg, The Netherlands), equipped with
scribed previously (Van Heugten et al., 1994). For
a CP-Sil 88-coated fused silica capillary column,
measurement of contraction frequency, car-
was used (Lamers et al., 1992).
diomyocytes were seeded on circular glass cover
slips (diameter 25 mm) at 150 to 175×103 cells/
cm2. For measurements of PLC-b activity or lactate
dehydrogenase (LDH) release, myocytes were Spontaneous contractions
seeded in wells with 1.8 cm2 surface at 150 to
175×103 cells/cm2. For the determination of cho- After 4 days, the culture grown on a circular glass
coverslip was rinsed once with incubation buffer I,lesterol content and total phospholipids, the car-
diomyocytes were seeded (150 to 175×103 cells/ containing 125 m NaCl, 5.0 m KCl, 2.5 m
CaCl2, 1 m MgSO4, 1 m KH2PO4, 10 m NaHCO3,cm2) in tissue culture dishes with 8 cm2 surface. For
measurement of membrane ¯uidity, cardiomyocytes 10 m N-2-hydroxyethylpiperazine-N′-2-ethane-
sulphonic acid (HEPES), and 5 m glucose (pH 7.4,were seeded on rectangular glass coverslips in sim-
ilar tissue culture dishes (diameter 35 mm, 8 cm2) 37°C), and subsequently mounted on a te¯on cul-
ture dish (Ince et al., 1985). The dish was placedat a density of 4×104 cells/cm2. Cell cultures were
grown at 37°C and 95% air/5% CO2 in complete in a temperature-controlled micro-incubator (Ince
et al., 1983) and the contractions of the cardio-growth medium consisting of Ham F10 sup-
plemented with 10% (v/v) fetal calf serum, 10% myocytes were visualized as described previously
(Le et al., 1993). The contracting cells were made(v/v) horse serum, 100 U penicillin/ml and 100 lg
streptomycin/ml. visible on a videomonitor, which was equipped with
an interactive system to convert the time-dependentThe cultures were exposed to the following con-
ditional growth media 24 h after seeding: (1) grey levels in a particular cursor-de®ned area on
the screen into a time-dependent voltage. This so-growth medium supplemented with the vehicle
[0.3% (v/v) pure ethanol]; (2) growth medium called contraction amplitude signal was counted in
a heart rate counter to obtain the contractionsupplemented with 18:0 and 18:1n-9 (107 l
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frequency signal expressed as beats/min. The ir- exchanging the growth medium for incubation buf-
fer, and pre-incubated with intracellular buffer.regularity of beating equalled the variation co-
ef®cient of the contraction frequency. After a 5-min pre-incubation period, a sample was
taken to measure the LDH release in the absence
of saponin. The buffer was subsequently removed
and replaced by intracellular buffer containing
Inositolphosphate production in intact and saponin-
100 lg/ml saponin.
permeabilized cardiomyocytes
Samples of the incubation buffer were taken
after 1, 2, 5 and 10 min, and stored on ice for
Cardiomyocytes were labelled with 2 lCi myo-[2-
determination of LDH release. Thereafter, the re-3H]Ins/ml for 48 h in conditioned growth medium.
mainder of the buffer was removed immediately
After washing and pre-incubation (15 min, 37°C)
and a solution of 1% Triton in intracellular buffer
in incubation buffer II, containing 130 m NaCl,
was added to release the rest of cellular LDH to
4.7 m KCl, 1.3 m CaCl2, 0.44 m NaH2PO4, determine the total LDH content of the cells. The
1.1 m MgSO4, 20 m NaHCO3, 11.1 m glucose, LDH activity was assayed spectrophotometrically
and 10 m HEPES (pH 7.4, 37°C), the cells were
in potassium phosphate buffer (95 m, pH 7.0),
stimulated with 5 l PHE or 5 n ET-1 in the
containing 7.6 m sodium pyruvate and 0.2 m
presence of 10 m LiCl. The incubations were
NADH, and was expressed as percentage of total
stopped by rapidly washing the cells with ice-cold
cellular LDH.
buffer. Water-soluble [3H]Ins products were ex-
tracted by two subsequent extractions with 4%
HClO4. The pooled HClO4 fractions were neutralized Membrane ¯uidity
with 2  KOH and 1  K2CO3. The remainder, i.e.
water-insoluble products, was extracted sub-
Membrane ¯uidity was assessed by measuring the
sequently with ice-cold CH3OH:HCl (100:1 v/v) for ¯uorescence steady-state anisotropy (rss) of the5 min at 4°C. The [3H]inositol phosphates ([3H]In-
plasma membrane speci®c ¯uorophore 1-(4-tri-
sPn) were separated from [3H]Ins and [3H]gly- methylammonium-phenyl)-6-phenyl-1,3,5-hexa-
cerophosphoinositol by chromatography on Dowex
triene p-toluenesulphonate (TMA-DPH), according
AG 1-X8 as described previously (Van Heugten et
to Sumbilla and Lakowicz (1983) and modi®ed by
al., 1994).
Bastiaanse et al. (1994). The cardiomyocytes grown
The myo-[2-3H]Ins pre-labelled cells were rinsed
on glass coverslips were washed twice and pre-
with phosphate-buffered saline, at 37°C, and sub-
incubated with incubation buffer I for 30 min at
sequently treated with 100 lg saponin/ml in in-
37°C. Thereafter, the cells were loaded with 10 l
tracellular buffer (10 m NaCl; 110 m KCl; 1 m
TMA-DPH for 30 min at 37°C. The glass coverslips
KH2PO4; 4 m MgCl2; ethylene glycol-O,O′-bis(2- were placed in a cuvette containing 2.5 ml buffer
aminoethyl)-N,N,N′,N′-tetraacetic acid (EGTA);
I, and after a period of 10 min the ¯uorescence
3 m ATP; 8 m creatine phosphate; 6 U/mol cre-
steady-state anisotropy (rss) was measured ac-atine kinase; 20 m HEPES; pH 7.0) for 5 min, by
cording to the following formula:
37°C. Thereafter, the myocytes were rinsed three
times with intracellular buffer followed by in-
rss=(Ivv−Ivh∗G)/(Ivv+2Ivh∗G) (1)cubation for 15 min at 37°C in intracellular buffer
containing 10 m LiCl, and about 96 n free Ca2+
where Ivv and Ivh represent the ¯uorescence in-ions (estimated according to SPECS, a software
tensities parallel and perpendicular to the excitation
program based on the formulas described by Fa-
plane (when set vertically), respectively. G is the
biato, 1988) with or without 30 l GTPcS. After
correction factor for the difference in the mono-
incubation, the collected buffer and the cells were
chromator's transmission ef®ciency for vertically
extracted for measurement of [3H]InsPn formation and horizontally polarized light, and equals Ihv/Ihh.as described previously (Van Heugten et al., 1994).
The measurements were performed on a spectro-
¯uorometer (Perkin-Elmer LS-3), provided with a
polarization accessory (Perkin-Elmer 5212-3269),
at 37°C.Rate of permeabilization induced by saponin
To validate the procedure, separate series of ex-
periments were conducted before and after theThe cardiomyocytes cultured with fatty acid en-
riched medium in 1.8 cm2 wells, were washed to membrane ¯uidity had been changed by addition
of the `` ¯uidizer'' 2-(2-methoxyethoxy)ethyl 8-(cis-remove the small amounts of LDH released upon
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2-n-octylcyclopropyl)-octanoate (A2C, 20 l). After ues, and analysis of variance was performed fol-
lowed by the Student±Newman±Keul's test whenmeasuring rss in the absence of A2C, the glass
coverslips were returned to their original pre-in- appropriate. A P-value less than 0.05 was con-
sidered to indicate statistical signi®cance.cubation loading dish, to which 20 l A2C was
added, and subsequently incubated for 30 min at
37°C. Immediately thereafter, the rss was measured
again. To ensure a maximal ¯uorescent signal, the Results¯uidity measurements were always carried out in
cells seeded at an optimal density (4×104 cells/
Irregularity in frequency of spontaneous contractionscm2), which was not in¯uenced by any fatty acid
treatment.
A previous study (Hallaq et al., 1992) using the
same model of cultured ventricular myocytes has
Free cholesterol and total phospholipids shown that incubation of the cells for 3±5 days
with 5 l 20:5n-3 prevented the arrhythmogenic
The myocytes cultured in fatty acid enriched effect of 0.1 m ouabain. No effect was seen when
medium grown in 8 cm2 dishes were rinsed twice the cells were pretreated with 5 l 20:4n-6. In the
with a physiological salt solution. The cells were present study, however, con¯uent monolayers of
scraped in 2 ml methanol and transferred to a glass control cells in con¯uency always exhibit spon-
tube (fat free) containing 0.75 ml physiological salt taneously irregular contractions. Figure 1(a) shows
solution. After addition of 1 ml CHCl3, the mixture typical recordings from the control ventricular myo-
was stirred vigorously. The supernatant was sep- cytes and those treated for 3 days with 18:0/18:
arated from the pellet by centrifugation (5 min, 1n-9, 18:2n-6 and 20:5n-3 rich medium. Pre-
3000 r.p.m.). The supernatant was stored on ice, treatment of cells with 18:2n-6 as well as with 20:
and the pellet was washed with 1.9 ml CHCl3: 5n-3 improved the regularity of the spontaneous
CH3OH:H2O (5:10:4 v/v/v). Again the supernatant contractions signi®cantly in comparison to control
was separated from the pellet by centrifugation and pretreatment [Fig. 1(b)]. This effect, however, was
added to the supernatant of the previous step. The not signi®cant compared to 18:0/18:1n-9. So it
pellet was discarded. Subsequently, 1.5 ml CHCl3 appears that the fatty acid pretreatment, in-
and 1.5 ml H2O were added to the supernatant dependently of the degree of polyunsaturation,
fraction, and after vigorous mixing and cent- induces a regular pattern of spontaneous con-
rifugation, the upper phase was separated from the tractions. As, in the model used, the cardiomyocytes
lower phase. The latter was dried with a little scoop are grown in a con¯uent monolayer, resulting in
of Na2SO4, and was stored at−20°C for 12 h. Then the spontaneous contractions, the particular area
the solution was transferred to a new glass tube, of monitoring by video could hardly be placed on
and the Na2SO4 pellet was washed with 1 ml CHCl3. a single cell, which would be necessary to assess
The wash ¯uid was combined with the solution. shortening in velocity. Therefore, no exact meas-
Subsequently, the organic phase was evaporated urements of the shortening velocity were performed.
and the residue dissolved in 200 ll peroxide-free 2-
propanol. Cholesterol was determined en-
zymatically using a kit (Boehringer, Mannheim,
Phospholipid fatty acid composition
Germany). In order to determine the total phos-
pholipid concentration, a sample of cell extract was
Incubation of myocytes with media enriched with
destructed with H2SO4:HClO4 (1:1 v/v) at 210°C for 18:0/18:1n-9, 18:2n-6 and 20:5n-3 changed the
5 h, until a clear solution was obtained. In this
fatty acid composition of the phospholipids (Table
solution, the phosphate concentration was quan-
1). Incubation with a 18:0/18:1n-9 supplemented
ti®ed according to Bartlett (1959), using a 1%
medium caused a markedly increased incorpora-
instead of a 0.22% ammoniumheptamolybdat so-
tion of 18:0 and 18:1n-9 fatty acids and a reduction
lution.
in 16:0, 18:1n-7, 18:2n-6 and 20:4n-6 contents.
As expected, the sum of PUFAs decreased from
47.0 to 38.5 mol%. Treatment with 18:2n-6 causedStatistics
a dramatic increase of 18:2n-6 from 17.1 to
38.9 mol %, associated with a decrease of 18:1n-9Data are presented as mean values±... unless
stated otherwise. Student's t-test was used for stat- and 20:4n-6. Furthermore, as expected, the sum
of PUFAs increased from 47.0 to 56.6 mol %. Treat-istical comparison with corresponding control val-
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changes in the ¯uidity of the membrane bilayer. As
can be seen from Table 1, the treatment with 20:
5n-3, in particular, caused a considerable increase
of DBI from 1.76 (control cells) to 2.33. Compared
to treatment with 18:0/18:1n-9 and 18:2n-6, the
20:5n-3-treated cells had much higher DBI. More-
over, in 18:2n-6-treated cells, a slight decrease from
1.76 to 1.60 was observed.
Agonist-induced [3H]InsPn response in intact
cardiomyocytes
Previously, the authors have shown that stimu-
lation of myo[2-3H]Ins-labelled neonatal rat vent-
ricular myocytes with either PHE or ET-1 results in
activation of PLC-b in a dose-dependent manner,
both agonists reaching about the same maximal
effect on the formation of total [3H]InsPn (Van Heug-
ten et al., 1993). To investigate the in¯uence of
an altered fatty acid composition of the plasma
membrane phospholipids on the agonist-induced
PLC activation, the cardiomyocytes grown in the
control medium and media enriched with 18:0/18:
1n-9, 18:2n-6 and 20:5n-3, were stimulated for
15 min with submaximal concentrations of PHE
(5 l) or ET-1 (5 n). The formation of [3H]InsPn
upon PHE and ET-1 stimulation, in cardiomyocytes
that were cultured in control medium, amounted
11% and 9.5%, respectively, of total incorporated
[3H]Ins, which was a 2.9 and 2.5 fold increase,
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respectively, compared to the basal [3H]InsPn pro-Figure 1 Frequency of spontaneous beating and re-
duction (3.8%) (Fig. 2). Pretreatment of car-gularity of beating frequency of ventricular myocytes
diomyocytes with 18:0/18:1n-9 or 18:2n-6grown in control medium (C, ±±±) or in 18:0/18:1 (SO,
±±±), 18:2n-6 (L, ±´±´) or 20:5n-3 (E, ´ ´ ´ ´ ) enriched enriched medium had no in¯uence on the PHE
medium. Cellular contractions were recorded using a stimulated [3H]InsPn formation. However, basalvideo technique, and were counted to obtain contraction [3H]InsPn formation in the 18:0/18:1n-9-treatedfrequency and irregularity of frequency. (a) A rep-
cells increased to 6.1% and the ET-1-stimulatedresentative experiment illustrating the frequency vs time
[3H]InsPn formation to 11.6%. Phenylephrinefor cardiomyocytes subjected to the various fatty acid
treatments. (b) The mean frequency (solid bars) and stimulation of cardiomyocytes pre-exposed to 20:
irregularity of frequency (open bars), measured over a 5n-3-rich medium resulted in signi®cantly less
period of 5 min (% VC: variation coef®cient) representing [3H]InsPn formation (7.3% of total incorporatedthe mean data of four different cell batches. Bars represent
[3H]Ins) compared with control cardiomyocytes,mean values±... ∗ P<0.05 vs control cells.
whereas stimulation with ET-1 of 20:5n-3-treated
cardiomyocytes caused a signi®cantly greater
[3H]InsPn formation (13.5% of total incorporatedment with 20:5n-3 led to the increased in-cor-
poration of this fatty acid (from 0.5 to [3H]Ins).
23.2 mol %) and its elongation product 22:5n-3
(from 2.7 to 9.7 mol %), but a decreased in-
corporation of 22:6n-3. The increased in- Ca2+ and GTPcS-induced [3H]InsPn response in saponin-
permeabilized cardiomyocytescorporation of n-3 PUFAs occurred mainly at the
expense of n-6 fatty acids, as the sum of PUFAs
The ®nding that the agonist-induced [3H]InsPnremained almost constant. The double bond index
(DBI; mean number of double bonds per mol fatty formation depends upon the fatty acid composition
of membrane phospholipids may be explained byacid) is a parameter that is indicative for possible
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Table 1 Fatty acid composition (mol %) of the total phospholipid fraction of ventricular
myocytes grown in control medium or in 18:0/18:1n-9 (SO), 18:2n-6 (L) or 20:5n-3 (E)
enriched medium
Fatty acids Control SO L E
(n=3) (n=3) (n=3) (n=4)
16:0 13.83±1.27 7.51±0.25 12.55±1.11§ 14.80±0.84§
18:0 23.31±0.56 28.24±0.51 21.08±0.94§ 23.03±1.12§
18:1n-7 3.09±0.06 1.68±0.10 2.04±0.07 2.59±0.05
18:1n-9 9.61±0.45 22.32±0.52 5.25±0.04 7.00±0.22
18:2n-6 17.10±1.43 14.43±0.93§ 38.87±0.88 6.08±0.48
20:4n-6 18.21±1.16 15.39±0.65§ 11.46±1.11 7.63±0.58
20:5n-3 0.48±0.07 1.12±0.55§ 0.20±0.05 23.22±1.31
22:5n-3 2.69±0.27 2.33±0.68§ 1.53±0.18 9.72±0.44
22:6n-3 3.71±0.34 2.38±0.26 1.67±0.14 1.33±0.07
Others∗ 7.97±0.06 4.59±0.83 5.36±0.22 4.60±0.14
DBI² 1.76±0.08 1.56±0.07 1.60±0.04 2.33±0.05∀
RPUFA³ 47.05±2.03 38.48±0.80 56.50±0.53 50.01±0.64
Values represent mean values±...
∗ Only the major fatty acids and the sum of minor fatty acids, termed `` others'' (mainly 16:0dma,
18:0dma, 18:3n-3, 20:3n-6, 22:0, 24:0 and 22:4n-6; dma; dimethylacetal) are listed.
² double bond index (mean number of double bonds per mole fatty acid).
³ RPUFA is the sum of all polyunsaturated fatty acids.
§ Values, not differing signi®cantly from control values. All other values were signi®cantly different
from control.
∀ P<0.05 in comparison to C, SO and L treatments.
changes at the level of agonist±receptor binding, dependent differences in the permeabilization. The
data illustrated in Figure 3 show that there was areceptor±G-protein coupling and/or G-protein±PLC-
b interaction. To study whether the G-protein±PLC- lagphase of LDH release up to 1 min of exposure to
saponin unaffected by either fatty acid treatment.b interaction is affected by changes in the fatty
acid composition of membrane phospholipids, the At 2 min, a signi®cant decrease was observed only
by 20:5n-3 treatment, and at 5 min, a small butmyo[2-3H]inositol-labelled cardiomyocytes (after ex-
posure to the different fatty acids) were per- not signi®cant decrease was observed only by 20:
5n-3 treatment. Figure 3, however, demonstratesmeabilized by saponin and then stimulated for
15 min with non-hydrolysable GTPcS in the pres- that 5±10 min of treatment with saponin resulted
in almost complete (70±80% of total LDH released)ence of Ca2+, or not stimulated. After per-
meabilization, about half of the [3H]InsPn formed depletion of LDH, which was independent of the
fatty acid supplementation. Therefore, at a timewas released in the incubation buffer. The basal
[3H]InsPn production (in buffer plus cell extract) of (2 min) of partial permeabilization, the car-
diomyocytes grown in 20:5n-3 rich medium, re-the permeabilized cardiomyocytes was not affected
by any of the fatty acid treatments (Table 2). GTPcS vealed signi®cantly less LDH release, that is 26%
as compared to 36% in cells grown in controlstimulation, in the presence of Ca2+, of the per-
meabilized cardiomyocytes pre-exposed to 20:5n-3 medium. A similar tendency of delayed LDH release
was observed in the 18:2n-6-treated cells.media resulted in signi®cantly less (4.2%) [3H]InsPn
formation compared to control cells (5.2%).
Cholesterol content and membrane ¯uidity
Saponin is believed to act mainly upon the cho-Resistance to saponin-induced permeabilization
lesterol component of the sarcolemma (Dour-
mashkin et al., 1962; Glauert et al., 1962). GivenAs can be seen in Table 2, the fatty acid treatment
dependent changes in [3H]InsPn formation released the results of 20:5n-3-induced changes in cellular
resistance to saponin permeabilization, the cho-in the buffer do not completely re¯ect the fatty acid
dependent changes in [3H]InsPn in the buffer plus lesterol content of whole cell extracts was de-
termined. Cholesterol is expressed either as nmol/cell extract, suggesting possible fatty acid treatment
H. W. de Jonge et al.1104
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Figure 2 Agonist-stimulated [3H]InsPn production in
Figure 3 The rate of permeabilization by saponinintact ventricular myocytes grown in control medium (C),
(100 lg/ml) as assessed by release of lactate de-or 18:0/18:1 (SO), 18:2n-6 (L) or 20:5n-3 (E) enriched
hydrogenase (LDH) from ventricular myocytes grown inmedium. Cardiomyocytes pre-incubated with myo-[2-
control medium (C, open bars) or in 18:0/18:1 (SO, solid3H]Ins were stimulated with either phenylephrine (PHE;
bars), 18:2n-6 (L, striped bars) and 20:5n-3 (E, stippled5 l, solid bars) or endothelin-1 (ET-1; 5 n, stippled
bars) enriched medium. LDH activity was assayed spec-bars) for 15 min at 37°C. Control cardiomyocytes, open
trophotometrically. Values are expressed as percentage ofbars). The cells were extracted and the [3H]InsPn formed
total cellular LDH, and represent mean values±...,was separated from the other [3H]Ins-labelled metabolites
in triplicate, of three different cell batches. ∗ P<0.05 vsas described in Methods. Values are expressed as per-
control.centage of total incorporated [3H]Ins and represent the
mean values±... of ®ve and four experiments, with
PHE and ET-1, respectively. ∗P<0.05, when comparing
agonist-mediated [3H]InsPn responses in cells cultured in was in the same range as that found for control cells
fatty acid enriched medium to the corresponding [3H]In-
in another report on the same model (Bastiaanse etsPn responses in cells pretreated with control medium.
al., 1994, 1995). Cholesterol expressed per nmol
phospholipid, however, did not change by these
fatty acid treatments (Fig. 4). This is due to the factmg protein or as nmol/nmol phospholipid (Fig. 4).
Exposure of cardiomyocytes to 18:0/18:n-9 and that phospholipid content (in nmol/mg protein) also
increased independently of the type of fatty acid18:2n-6 resulted in a slight increase in cellular
cholesterol content of 35 and 40 nmol/mg protein, treatment (see legends to Fig. 4). It was most
remarkable to observe that 20:5n-3 pretreatmentrespectively, as compared to 28 nmol/mg protein
in control cells (Fig. 4). This cholesterol content produced a three-fold increase in cellular cholesterol
Table 2 GTPcS stimulated total [3H]inositol phosphate ([3H]InsPn) production in the presence of Ca2+ in saponin-
permeabilized ventricular myocytes grown in control medium (C) or in 18:0/18:1n-9 (SO), 18:2n-6 (L), or 20:5n-3 (E)
enriched medium
[3H]InsPn production (% of total cellular [3H]Ins)
C SO L E
Incubation buffer only
−GTPcS 1.13±0.08 0.87±0.07∗ 0.86±0.07∗ 1.01±0.08
+GTPcS 3.10±0.17 2.96±0.23 2.46±0.10∗ 2.52±0.20∗
Buffer plus cell extract
−GTPcS 2.23±0.10 1.81±0.18 2.19±0.32 2.11±0.16
+GTPcS 5.19±0.31 4.78±0.36 4.53±0.24 4.19±0.29∗
Values are expressed as percentage of total incorporated [3H]Ins and represent the mean values±... of eight measurements.
∗ P<0.05 vs control.
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grown in control medium (C), or in 18:0/18:1 (SO), 18:
2n-6 (L) or 20:5n-3 (E) enriched medium. (a) VentricularFigure 4 Cholesterol content of ventricular myocytes
myocytes grown in control medium (C) or in 18:0/18:1grown in control medium (C), or in 18:0/18:1 (SO), 18:
(SO), 18:2n-6 (L) and 20:5n-3 (E) enriched medium were2n-6 (L) or 20:5n-3 (E) enriched medium. Cholesterol
loaded with the ¯uorophore diphenylhexatriene, TMA-was determined enzymatically in cellular extracts, and
DPH for 30 min, at 37°C, whereafter the ¯uorescencethe total phospholipids in the extracts were determined by
steady-state anisotropy rss of the ¯uorophore TMA-DPHassessment of the phosphate concentration as described in
was assessed as described in detail in Methods. (b) ToMethods. Cholesterol is expressed either as nmol/mg
validate the experimental method, rss was measured be-protein (solid bars) or as nmol/nmol phospholipid (open
fore and after addition of the membrane mobility agentbars). Phospholipid content (nmol/mg protein) did also
A2C to TMA-DPH-loaded ventricular myocytes. Values arechange, however, independently of the fatty acid treat-
expressed as mean values±... of three experiments.ment: C, 134±13; SO, 176±15; L, 192±18; E,
∗ P<0.05 vs control.217±27 (P<0.05, fatty acid treatment vs control). Values
represent mean values±... of seven to eight de-
terminations. ∗ P<0.02 vs control; ² P<0.001 vs C, SO,
and L; ³ P<0.005 vs C, SO and L. Discussion
The aim of this study was to investigate the in-
¯uence of increased n-6 and n-3 PUFA in-
content expressed per mg protein and a 1.7-fold corporation in the phospholipids of the
increase in cholesterol expressed per nmol phos- cardiomyocyte membrane on the PHE- and ET-1-
pholipid. The increase in cholesterol content per stimulated PtdIns cycle, as compared with cells
mg protein was much more dramatic compared grown in unsupplemented growth medium. More-
with those seen with 18:0/18:1n-9 (1.2-fold) and over, in comparison, similar experiments were per-
18:2n-6 (1.4-fold) treatment. Because of the large formed with saturated/monosaturated fatty acid
changes observed in membrane cholesterol and DBI pretreated cells. The mixture of the supplemental
due to 20:5n-3-treatment of the cardiomyocytes, free PUFAs with the concentrated horse and calf
the membrane ¯uidity was assessed by measuring sera, the latter contain an excess of fatty-acid-poor
the ¯uorescence steady-state anisotropy (rss) of albumin molecules, ensured that the toxicity of a
TMA-DPH. Indeed, only the rss of cardiomyocytes high concentration of non-esteri®ed fatty acids was
grown in 20:5n-3 was signi®cantly (P<0.02) af- prevented. This was also based upon earlier studies
fected, that is increased by 8% as compared to in which it was shown, in in vitro experiments, that
control cultures [Fig. 5(a)]. Apparently, the bilayer cardiac sarcolemmal membrane kept its integrity if
`` stiffening'' effect of an adaptively increased cho- the non-esteri®ed fatty acid to albumin molar ratio
lesterol content overcompensates for the ¯uidizing did not exceed 5 (Lamers et al., 1984). Moreover, in
effect of increased degree of polyunsaturation of the present study, the control cells usually exhibited
fatty acids in the phospholipids. To validate the irregularities in their contraction frequency,
method of ¯uidity measurement, a separate series whereas treatment with n-6 and n-3 PUFAs im-
of experiments was performed to determine whether proved signi®cantly the regularity of spontaneous
the rss value was in¯uenced by the membrane contractions. A tendency to such improvement was
mobility agent A2C [Fig. 5(b)]. Before and after also seen after treatment with 18:0/18:1n-9.
exposure to 20 l A2C for 30 min, the rss of control Although the free fatty acid enriched incubation
cardiomyocytes was measured to revealed an in- medium was always washed away carefully, fol-
crease of ¯uidity, i.e. a signi®cant (P<0.05) decrease lowed by a period of stabilization before agonist
stimulation of the cardiomyocytes, the additionalof rss by 15.4%.
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in¯uence of an altered composition of the non- Although in the latter study the changes of phos-
pholipid fatty acid pro®le were obtained phar-esteri®ed fatty acid pool which is performed by the
normal turnover of cellular phospholipids can not macologically by repeated administration of
hydrocortisone and/or epinephrine, the enhancedbe excluded. In neonatal cardiomyocytes, exo-
genous free n-3 PUFAs were found to exert their incorporation of 18:2n-6, 20:4n6 and 22:6n-3
in phosphatidylcholine and phosphatidyleth-effect directly on Ca2+-channels, as was assessed
by measurement of the steady-state Ca2+ in¯ux anolamine paralleled the decreases in af®nity of the
a1-adrenoceptors and coincided with down-(Hallaq et al., 1992) and of the cell contractions
mediated by b-adrenergic stimulation of the cells regulation of the number of b-adrenergic binding
sites. Next to the fact that the mechanisms re-(Kang and Leaf, 1995). The b-adrenergic-agonist-
induced arrhythmias could be prevented by exo- sponsible for a1- and b-adrenoceptor regulation are
different, it was speculated by SkuÂ ladoÂttir et al.genous non-esteri®ed 20:5n-3, but revived when
the fatty acid was washed away with fatty-acid- (1993) that because adrenoceptors span the entire
thickness of the membrane bilayer, a change infree albumin (Kang and Leaf, 1995).
The various fatty acid treatments of the car- membrane phospholipid acyl chains could result in
an increase in bilayer volume associated with adiomyocytes resulted in the expected alteration of
fatty acid composition of the membrane phos- conformational change in the membrane receptor.
Although the results of the present study indicatepholipids. In 18:2n-6-treated cells, incorporation
of 18:2n-6 increased from 17.1 (control cells) to that the level of agonist±receptor is an important
step in the impoundment of alterations in the phos-38.9 mol %, while in the 20:5n-3-treated cells,
incorporation of 20:5n-3 and its elongation product pholipid fatty acid pro®le on the PtdIns-cycle, the
effects are certainly not restricted to this level. The22:5n-3 increased from 0.5 and 2.7 mol % (control
cells), respectively, to 23.2 and 9.7 mol %, re- effect of polyunsaturated fatty acid incorporation
in the phospholipids on the membrane dynamicspectively. However, a marked increase in double
bond index was observed in 20:5n-3-treated cells characteristics, such as ¯uidity, membrane cho-
lesterol in correlation to integrity might in¯uencealone (2.33), in comparison with values of 1.76 in
control, 1.60 in 18:2n-6-treated cells, and 1.56 in the process of activation and the maintenance in
the PtdIns-cycle on one hand. On the other hand,18:0/18:1n-9-treated cells. As far as the PtdIns
cycle is concerned, the most remarkable effects the induced alterations in the molecular species of
PtdIns(4,5)P2 is also likely to be of importance.were observed in the 20:5n-3-treated ventricular
myocytes. In those myocytes, the PHE- and ET-1- The direct stimulation of the G-proteins of sap-
onin-permeabilized cardiomyocytes with GTPcSstimulated PLC-b response measured in intact cells
was decreased (7.3% of total incorporated [3H]Ins) showed an attenuation of total [3H]InsPn ac-
cumulation in 20:5n-3-treated cells, as was meas-and increased (13.5% of total incorporated [3H]Ins),
respectively, compared to ventricular myocytes ured in the cell extract plus incubation buffer. When
the results on [3H]InsPn formation in the buffer andgrown in control medium (respectively 11 and 9.5%
of total incorporated [3H]Ins). In 18:2n-6-treated cell extract were compared to those in the buffer
alone, slight discrepancies show up concerning thecells, no signi®cant effect was observed on receptor-
mediated PLC-b activity. Also, treatment with 18:0/ effects of various fatty acid treatments. Thus, dif-
ferences in permeabilization by saponin of the fatty-18:1n-9 led to a slight increase of the ET-1-stim-
ulated PLC-b response. Previously, the authors have acid-treated cardiomyocytes could have occurred.
However, investigation of the time course of sap-shown that the effects of 20:5n-3 on agonist-in-
duced [3H]InsPn formation can not be ascribed to onin-induced permeabilization of cardiomyocytes,
measured by the release of LDH, unmasked a mem-the alterations in the relative [3H]Ins incorporation
in phosphorylated PtdIns (Lamers et al., 1992). brane protecting effect of 20:5n-3-pretreatment
of the cardiomyocytes. The membrane per-Similar results were found by Bordoni et al. (1990)
when cells were grown in 22:6n-3-enriched meabilization by saponin is generally believed to be
caused by complexation with cholesterol in themedium. The results, obtained with the saponin
permeabilized cardiomyocytes, suggest that the ef- plasma membrane, leading to instability of the
bilayer (Dourmashkin et al., 1962; Glauert et al.,fects of 20:5n-3 on receptor-mediated PLC-b of
intact cardiomyocytes could be exerted at the level 1962). The inter-relationship between membrane
stability, ¯uidity and cholesterol content of theof either the agonist±receptor, receptor±G-protein
coupling or G-protein±PLC-b interaction. In view bilayer, and DBI of the acyl groups in the phos-
pholipids could be the basis of the unexpected ®nd-of these ®ndings, the observations of SkuÂ ladoÂttir et
al. (1993) in adult cardiomyocytes are interesting. ing of a membrane protective effect of 20:5n-3-
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treatment of cardiomyocytes towards the per- colemmal ¯uidity that was observed after metabolic
inhibition was caused by a decrease in sarcolemmalmeabilizing agent, saponin. The massive increase
of cholesterol induced by 20:5n-3-treatment may free cholesterol content.
In conclusion, in neonatal ventricular myocytes,initially protect the membrane for the cholesterol
clustering, destabilizing and subsequent per- the activity of the PtdIns cycle is affected by 20:
5n-3 treatment of the cardiomyocytes and this effectmeabilizing action of saponin.
In addition, 20:5n-3-treatment-induced al- could be exerted at either the level of agonist±
receptor, receptor±G-protein coupling or G-protein±terations in the plasma membrane ¯uidity and
chemical composition, e.g. molecular species of PLC-b interaction. It is hypothesized that a causal
relationship may exist between the 20:5n-3-in-phospholipids and/or cholesterol content, could me-
diate changes in the PtdIns-cycle activity was found duced alteration of the physicochemical properties
in the bilayer and the agonist-dependent effects onto be most dramatic in n-3-PUFAs-treated atrial
cells when comparing rats fed with n-6 PUFAs, the PtdIns-cycle activity.
mono-unsaturated or saturated fatty acids (Wood-
cock et al., 1995).
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